INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Patient Recruitment

A dedicated team that builds innovative strategies to achieve your enrollment milestones in dermatology and rheumatology clinical trials.

Let’s talk

Indications

0 +
 Years of Experience
1 +
Patients in Clinago, Our Patient Database
12475 +

All in with Patient Recruitment

At Indero, our dedicated patient recruitment and advertising team works closely with our project management team to develop innovative strategies tailored to your clinical trials.

  • White-glove service
  • Dedicated patient recruitment strategist
  • Site training and onboarding for our recruitment platform, Clinago
  • Optimize site enrollment activities with multichannel advertising and local ad support
  • Develop ads that connect with the target population
  • Expertise in navigating strict requirements from regulatory bodies, ethics committees, social media, search platforms, and other red tape associated with patient recruitment
  • Create enrollment projections based on site communications and timelines
  • Support throughout the trial, including campaign monitoring and escalation planning
  • Proactive identification and mitigation of recruitment risks
  • Offer study branding to boost awareness and engagement
  • Provide guidance on recruitment and advertising best practices

Celebrating 25 Years of Therapeutic Excellence

For a quarter-century, Indero has been the trusted CRO partner for biotech and pharmaceutical leaders across the globe, delivering precision, reliability, and innovation in dermatology and rheumatology clinical trials.

Learn more

Recruit & Refer Pre-Qualified Patients for Dermatology & Rheumatology Clinical Trials

Indero’s proprietary recruitment solution, Clinago. is a sophisticated, patient-facing platform that connects 12,000+ patients to sites, allowing seamless and active recruitment and referral
of pre-qualified participants.

Comprehensive database of patients

  • Preliminary patient identification
  • Accelerated recruitment
  • Improved patient retention
  • Decreased need for advertising

 

Site engagement

  • Real-time monitoring of prescreening activities 
  • Fast identification of sites in need of support
  • Direct contact with the site for patients

State-of-the-art website

  • Integrated online pre-screener for fast patient pre-qualification
  • Secured individual patient profile including medical information
  • Study-specific landing pages, sharing relevant information with patients and sites

 

Seamless website management

  • Automated notifications and reminders
  • Available support
  • Patient referrals

Samantha Stefanin, RPN. BA

Research Study Coordinator

“What our site likes most about Clinago is its high success rate in finding eligible patients. It has improved our screen failure rate, and as a result, we can help more people!”

Ad Development & Patient Advocacy Groups

Images & Content 

Our experts create tailored ads, landing pages, online pre-screener templates, and other recruitment materials specifically for dermatology and rheumatology. 

Patient Advocacy Support 

To recruit the right patients for your study, we collaborate with more than 100 dermatology and rheumatology patient advocacy groups (PAGs) across the globe.

A Selection of the PAGs We Work With

Partner with Indero’s Patient Recruitment Team

Indero’s patient recruitment team has expertise in recruitment modeling for dermatology and rheumatology clinical trials, helping you get ahead of risks and maximize enrollment—fast. Tell us about your clinical trial goals today.

Let’s talk

Maximizing Patient Exposure in a Competitive Clinical Trial Market

While alopecia areata is a competitive space, the Indero patient recruitment team brainstormed ways to increase patient engagement and boost enrollment. By introducing a central campaign, which became our most successful to date, the study reached its randomization target 3 months early.

Challenges

  • New drug approval changing the standard of care in alopecia areata introduced a plateau in US recruitment 
  • Sites work through databases faster and have a hard time finding patients with SALT scores between 50–95%

Strategy & Results

  • Central campaign, including public relations and geotargeted advertising elements, launched once 50% of the sites were activated
  • Introduced an awareness campaign to boost central campaign results: 
    • 55% of AA patients enrolled with Clinago

Patient Recruitment Services that Accelerate Studies

Scientific discipline. Operational efficiency. Clinical development expertise. Our patient recruitment services provide the rigorous foundation, quality data, and expertise dermatology and rheumatology studies need to ensure effective execution and on-time delivery.

ABOUT INDERO

We can always rely on them.

“We are thrilled to have had such a longstanding and professional relationship with Indero. We know that we can always rely on them to put their central campaign expertise and advertisement knowledge within the clinical research industry to good use.”

Dr. Mark Lee

Progressive Clinical

Research

Wherever You’re Going,
We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Talk to us

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >